Tuberculous pneumonia is an inflammatory syndrome of the lungs caused by infection with Mycobacterium tuberculosis, which is usually characterized by low-grade fever in the afternoon, cough, sputum, hemoptysis, and fatigue.
Tuberculous pneumonia usually manifests as caseous pneumonia, with respiratory symptoms including but not limited to cough, sputum, chest pain, hemoptysis and other symptoms, accompanied by systemic symptoms such as afternoon low-grade fever, night sweats, malaise, poor appetite, mental depression and so on.
Clinical standardized anti-tuberculosis treatment, such as isoniazid, ethambutol, rifampicin, pyrazinamide, streptomycin, etc., is usually given, and the course of treatment usually lasts for 9 to 12 months.
Sputum-positive tuberculosis patients are an important source of infection, and it is recommended that when living with them in daily life, wearing a mask, ventilating the room diligently, and sterilizing the sputum well can generally prevent causing Mycobacterium tuberculosis infection.
Tuberculous pneumonia, which is an infectious disease, should receive standardized treatment in local hospitals. The above medications should be used under the guidance of a physician.